THE ROLE OF THE PREMORBID THYROID STATUS IN THE FORMATION OF CELLULAR IMMUNITY AND THE CONSEQUENCES OF CHEMOTHERAPY IN PATIENTS WITH DESTRUCTIVE PULMONARY TUBERCULOSIS

Authors

  • Matveyeva S. L. Kharkiv National Medical University, Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2011.3.06

Keywords:

pulmonary tuberculosis, thyroid gland, cellular immunity, consequences of anti-tuberculosis chemotherapy

Abstract

The indicators of the state of the thyroid gland and cellular immunity were studied in patients with newly diagnosed pulmonary tuberculosis (TP). A comparative analysis of the efficacy of anti-tuberculosis chemotherapy in patients with thyroid pathology and unchanged thyroid status was carried out. Changes in the echostructure of the thyroid gland were found in 51% of patients. In the case of TP in combination with an altered echostructure of the thyroid gland, a decrease in the level of free thyroxine and an increase in the level of TSH were found as compared with the group of patients with TP without thyropathy. The interleukin-6 level in patients with LT combined with thyroid pathology is significantly lower than in patients without thyropathy. The effectiveness of chemotherapy in tuberculosis patients without thyropathy is higher than in tuberculosis patients with thyropathy. It was concluded that it is necessary to screen the state of the thyroid gland in order to identify hidden disorders of the functional activity of the thyroid gland in order to correct them, restore the cytokine balance and increase the effectiveness of anti-tuberculosis chemotherapy

References

Is there a need to redefine the upper normal limit of TSH? [Text] / G. Brabant, P. Beck-Peccoz, B. Jarzab [et al.] // Europ. J. Endocrinol. — 2006 — Vol. 154. — P. 633–637.

De Groot, L. The causes of autoimmune thyroiditis (Hashimoto disease) [Text] / L. De Groot, J. Quintans // Endocrinol. Rev. — 1989. — Vol. 10 — P. 537–562.

Involvement of thyroid hormones in the alterations of T-cell immunity and tumour progression [Text] / L. R. Frick, M. Rapanelli, U. A. Bussman [et al.] // Biol. Psychiatry. — 2009. — Vol. 65 (11) — P. 935–942.

Петренко, В. I. Роль цитокiнiв та застосування їх з метою iмунокорекцiї у хвор их на туберкульоз легень [Текст] / В. I. Петренко, Ю. А. Варченко // Туберкульоз. Легеневi хвороби. ВIЛ-iнфекцiя. — 2010. — № 2. — С. 78–85.

Черенько, С. О. Визначення цитокинового профiлю периферичної кровi та бронхоальвеолярного лаважу у хворих на туберкульоз та не госпiтальну пневмонiю iз диференцiйно-дiагностичною метою [Текст] / С. О. Черенько, Н. О. Скороходова,

О. I. Шпак // Укр. пульмонол. журн. — 2009. — № 23. — С. 24–28.

Impaired immune responses in tuberculosis patients are related to weight loss that coexists with immunoendocrine imbalance [Text] / C. Mahuad, V. Bozza, S. M. Pezzotto [et al.] // Clin. Exp. Immunol. — 2007. — Vol. 14 (3–4). — P. 193–199.

Матвеева, С. Л. Клиническая характеристика и исходы химиотерапии у лиц с патологией щитовидной железы [Текст] / С. Л. Матвеева // Туберкульоз. Легеневi хвороби. ВIЛ-iнфекцiя. — 2011. — № 2 (05). — С. 35–44.

Thyrotropin levels in a population with no with no clinical, autoantibody, or ultrasound evidence of thyroid disease; implications for the diagnosis of subclinical hypothyroidism [Text] / T. E. Hamilton, S. Davis, L. Onstad, K. J. Rjpecky // J. Clin. Endocrinol. Metabol. — 2002. — Vol. 87. — P. 489– 499.

Subclinical thyroid dysfunctions: a joint statement on management from the American Association of Clinical Endocrinologists. The American Thyroid Association and Endocrine Society [Text] / H. Gharib, R. M. Turtle, H. L. Baskin [et al.] // J. Clin. Endocrinol. Metabol. — 2005 — Vol. 90 (1) — P. 581–585.

Howlett, D. C. Sonographic assessment of the thyroid gland — a Pictorial Review [Text] / D. C. Howlett // Ultrasound. — 2008. —

Vol. 16. — P. 36–42.

Thyroid hormone analogues potentiate the interferon-gamma by two mechanisms [Text] / H. Y. Lin, H. Thacore, F. B. Davies [et al.] // J. Cell. Physiol. — 1996. — Vol. 167 (2). — P. 269–276.

Potentiation by thyroxine of interferon-gamma-induced HLA-DR expression is protein kinase Aand C-dependent [Text] / H. Y. Lin, H. Thacore, F. B. Davies [et al.] // J. Interferon Cytokine Res. — 1996. — Vol. 16 (1). — P. 17–24.

Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 monthes of adalimumab treatment: a pilot study [Text] / H. G. Paterman, A. Jamnitski, W. F. Lems [et al.] // J. Rheumatology. — 2010. — Vol. 12.

2002 serum TSH, T4 and thyroid antibodies in the United States population (1988–1994): National Health and Nutrition Examination (NHANES 111) [Text] / J. G. Hollowell, N.W. Staehling, W. D. Flanders [et al.] // J. Clin. Endocrinol. Metabol. — 2002 — Vol. 87. — P. 489–499.

Нумганова, Л. Б. О референтных значениях тиреотропного гормона [Текст] / Л. Б. Нумганова, Т. Р. Чжен, Р. Б. Абдазова // Мiжнар. ендокринол. журн. — 2009. — Т. 23, № 5. — С. 141–144.

Zophel, K. Should we really determine a reference population for the definition of thyroid-stimulating hormone reference interval? [Text] / K. Zophel, G. Wunderlich, J. Kozerke // Clin. Chemistry. — 2006. — Vol. 52. — P. 329–330.

Zosin, I. The Importance of Screening of Thyroid Dysfunctions [Text] / I. Zosin // Мiжнар. ендокринол. журн. — 2009. — Т. 19, № 1. — С. 33–45.

Waise, A. The upper limit of the reference range for thyroid-stimulating hormone should not be confused with a cut-off to define subclinical hypothyroidism [Text] / Waise A., Price H. C. // Ann. Clin. Biochemistry. — 2009. — Vol. 46. — P. 93–98.

Biondi, B. The clinical significance of subclinical thyroid dysfunction [Text] / B. Biondi, D. S. Cooper // Endocrin. Rev. — 2008 — Vol. 29 (1). — P. 76–131.

Serum concentration of cytokines in patients with active tuberculosis (TB) and after treatment [Text] / A. Verbon, N. Suffermans, S. J. H. Van Deventer, T. Van Der Poll // Clin. Exp. Immunol. — 1999. — Vol. 115. — P. 110–113.

Post-thyroidectomy thyroxine replacement dose in patients with or without compensated heart failure [Text] / N. Papanas, K. Papatheodorou, B. Papazoglou [et al.] // Cytokine. — 2008. — Vol. 41 (2). — P. 121–126.

Van Snick, J. Interleukin 6; an overview [Text] / J. Van Snick // Ann. Rev. Immunol. — 1990. — Vol. 8. — P. 253–278.

Shiratsuchi, H. Bidirections effects of cytokines on the growth of M.avium within human monocytes [Text] / H. Shiratsuchi, J. L. Johnson, J. J. Ellner // J. Immunol. — 1991. — Vol. 146. — P. 3165–3170.

Vallis, R. S. Cytokines and tuberculosis [Text] / R. S. Vallis, J. J. Ellner // J. Leuk. Biol. — 1994. — Vol. 55. — P. 676–681.

Lethal tuberculosis in interleukin-6 deficient mutant mice [Text] / C. H. Ladel, C. Blum, A. Dreher [et al.] // Infect. Immun. — 1997. — Vol. 65. — P. 4843–4849.

Reinfenberg, K. Lethal tuberculosis in interleukin6-deficient mice [Text] / K. Reinfenberg, M. Kopf, S. H. Kaufmann // Infect. Immun. — 1997. — Vol. 65. — P. 4843–48491.

Preliminary evidence of immune function modulation by thyroid hormones in healthy men and women aged 55–77 years [Text] / C. F. Hodkinson, E. E. A. Simpson, J. H. Beattie [et al.] // J. Endocrinol. — 2009. –Vol. 202. — P. 55–63.

Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans [Text] / J. M. Stouthard, T. Van der Poll, E. Endert [et al.] // J. Clin. Endocrinol. Metabol. — 1994. — Vol. 79. — P. 1342–1346.

Tumour necrosis factor: a putative mediator of the sick euthyroid syndrome in man [Text] / T. Van der Poll, J. A. Romijn, W. M. Wiersinga [et al.] // J. Clin. Endocrinol. Metabol. — 1990. — Vol. 71. — P. 1567–1572.

Interleukin-6 inhibits human thyroid peroxidase gene expression [Text] / T. Tominaga, S. Yamashita, Y. Nagayama [et al.] // Acta Endocrinol. — 1991. –Vol. 124. — P. 290–294.

Wilson, G. R. Subclinical thyroid disease [Text] / G. R. Wilson, P.W. J. Curry // Am. Fam. Physician. — 2005. — Vol. 72 (8). —

P. 1517–1524.

Downloads

Published

2011-09-27

How to Cite

Matveyeva, S. L. (2011). THE ROLE OF THE PREMORBID THYROID STATUS IN THE FORMATION OF CELLULAR IMMUNITY AND THE CONSEQUENCES OF CHEMOTHERAPY IN PATIENTS WITH DESTRUCTIVE PULMONARY TUBERCULOSIS. Problems of Endocrine Pathology, 37(3), 35-43. https://doi.org/10.21856/j-PEP.2011.3.06

Issue

Section

CLINICAL ENDOCRINOLOGY